BioSpace News Archive

Varex Imaging Corporation (Nasdaq: VREX) today announced it has priced a private offering (the “Offering”) of $300 million aggregate principal amount of 7.875% senior secured notes due 2027 (the “notes”) at an offering price of 100% of the principal amount thereof

Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that it has re-activated study sites and recommenced patient recruitment in a Phase 2 study of NYX-2925 in patients with fibromyalgia.

Sangamo Therapeutics, Inc., a genomic medicine company, announced that management will present at the following investor conferences

Cerus Corporation (Nasdaq:CERS) announced today its lineup of abstract presentations at the AABB 2020 Virtual Annual Meeting, which will take place on October 3rd through October 5th.

Jaguar Health, Inc. (NASDAQ:JAGX) announced today that the company’s wholly owned subsidiary, Napo Pharmaceuticals, Inc. (Napo), is a proud sponsor of this year’s National Trans Visibility March (NTVM), a week-long virtual event beginning September 28, 2020.

Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) today announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,772,907 (the ‘907 Patent) and allowed U.S. Patent Application No. 16/557,597 (the ‘597 Application), both entitled “Immune Modulation with TLR9 Agonists for Cancer Treatment” and each of which includes the Company’s investigational therapy tilsotolimod.

The Preeclampsia Foundation is urgently calling for the development of biomarker tests for simple, rapid, and accurate diagnosis and prediction of preeclampsia, a life-threatening hypertensive disorder of pregnancy.

The National Comprehensive Cancer Network® (NCCN®) today announced the publication of new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Pediatric Hodgkin Lymphoma.

Stryker’s Trauma & Extremities division today announced the launch of its T2® ICF Intramedullary nailing system, offering a solution for patients suffering from serious foot conditions such as Charcot foot—a condition associated with diabetes resulting in poor bone quality, possible nerve damage and potential foot ulcers

Covetrus, a global animal-health technology and services company, announced the agenda and speaker lineup for its annual VetSummit conference that is to take place October 16-18.